Literature DB >> 9178861

Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.

F Wavrant-DeVrièze1, J Pérez-Tur, J C Lambert, B Frigard, F Pasquier, A Delacourte, P Amouyel, J Hardy, M C Chartier-Harlin.   

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder affecting elderly people. It usually occurs after 65 years old (late-onset AD). The epsilon4 allele of apolipoprotein E (APOE) gene is a risk factor which contributes about 50% of the genetic risk for this form of the disease. The low density lipoprotein receptor-related protein (LRP) is a major receptor for APOE which is found in the senile plaques of AD brains. This makes it a good candidate gene for the disease. There is a polymorphism in the region upstream of the LRP gene that has been associated with AD in an American population. We examined this polymorphism by restriction fragment length polymorphism analysis in a French population with sporadic late-onset AD. In the previous report, a significant increase of the 87 bp allele was found in the AD cases; however, in our population, we observed a significant decrease with this same allele of the LRP gene. The possible reasons for this discrepancy, linkage disequilibrium or statistical anomaly, are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178861     DOI: 10.1016/s0304-3940(97)00304-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 2.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

3.  Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity.

Authors:  W K Scott; J M Grubber; P M Conneally; G W Small; C M Hulette; C K Rosenberg; A M Saunders; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

4.  Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases.

Authors:  Y Hashimoto; H Jiang; T Niikura; Y Ito; A Hagiwara; K Umezawa; Y Abe; Y Murayama; I Nishimoto
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 5.  The genetics of Alzheimer's disease.

Authors:  G D Schellenberg; I D'Souza; P Poorkaj
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

6.  Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.

Authors:  Ellen M Wijsman; E Warwick Daw; Change-En Yu; Haydeh Payami; Ellen J Steinbart; David Nochlin; Erin M Conlon; Thomas D Bird; Gerard D Schellenberg
Journal:  Am J Hum Genet       Date:  2004-07-08       Impact factor: 11.025

7.  Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.

Authors:  J H Lee; R Mayeux; D Mayo; J Mo; V Santana; J Williamson; A Flaquer; A Ciappa; H Rondon; P Estevez; R Lantigua; T Kawarai; A Toulina; M Medrano; M Torres; Y Stern; B Tycko; E Rogaeva; P St George-Hyslop; J A Knowles
Journal:  Mol Psychiatry       Date:  2004-11       Impact factor: 15.992

8.  Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family.

Authors:  Judy A Cam; Guojun Bu
Journal:  Mol Neurodegener       Date:  2006-08-18       Impact factor: 14.195

9.  Receptor-associated protein (RAP) plays a central role in modulating Abeta deposition in APP/PS1 transgenic mice.

Authors:  Guilian Xu; Celeste Karch; Ning Li; Nianwei Lin; David Fromholt; Victoria Gonzales; David R Borchelt
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240

10.  Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice.

Authors:  A Trueba-Sáiz; C Cavada; A M Fernandez; T Leon; D A González; J Fortea Ormaechea; A Lleó; T Del Ser; A Nuñez; I Torres-Aleman
Journal:  Transl Psychiatry       Date:  2013-12-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.